Teva Pharmaceutical Industries Limited
NYSETeva Pharmaceutical Industries enters the week with a rare burst of momentum. A strong Q1 earnings print sent the stock up nearly 11% on April 29 alone. The stock is now up 13% on the week and 19% over the past month, trading at $35.86. The Street has followed — and the question now is whether the setup can hold into the next print on May 28. The analyst response to Q1 has been…
Snapshot as of 6 May 2026
Teva Pharmaceutical Industries enters the week with a rare burst of momentum. A strong Q1 earnings print sent the stock up nearly 11% on April 29 alone. The stock is now up 13% on the week and 19% over the past month,…
TEVA heads into its May 6 Q1 results on the back of a rare wave of unanimous bullishness from the Street, with the stock already up 14% on the week and 16% over the past month to $34.95. The analyst signal here is…
TEVA reports Wednesday morning with its short positioning at a three-month low and options traders showing little conviction either way. Short interest fell 14% over the past month to 26.7 million shares. Cost to…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TEVA — free to start on ORTEX.
Sign up for free →Open TEVA on ORTEX